Shares of Cencora Inc. COR shed 1.28% to $243.59 Wednesday, on what proved to be an all-around grim trading session for the ...
In yet another move to pay down debt that matures in 2026, Walgreens Boots Alliance announced last night it would receive ...
Hosted on MSN1d
Cencora Stock Outlook: Is Wall Street Bullish or Bearish?Headquartered in Conshohocken, Pennsylvania, Cencora, Inc. (COR) is a leading pharmaceutical services company dedicated to ...
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...
The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10 ...
Leerink Partnrs dropped their Q2 2025 EPS estimates for Cencora in a report released on Wednesday, February 5th. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $4.08 per ...
The Department of Government Efficiency (DOGE), Elon Musk’s project, has already put HUD programs under a microscope, put $12 ...
The Trump administration’s moves to trim government spending pose a short-term “understated risk” for companies all across ...
Over the past year, many Cencora, Inc. (NYSE:COR) insiders sold a significant stake in the company which may have piqued investors' interest. Knowing whether insiders are buying is usually more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback